Development of An Innovative TEE Technology for Mutation Detection
Development of An Innovative TEE Technology for Mutation Detection
批准号:
10757697
负责人:
Qipan Deng
金额:
$107.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-18 至 2025-08-31
关键词:
AftercareAllelesBRAF geneBiological ModelsBloodCancer DetectionCancer PatientClinicalCodon NucleotidesDNADNA Mutational AnalysisDNA SequenceDetectionDevelopmentDiagnostic testsDideoxy Chain Termination DNA SequencingDrug TargetingEffectivenessEligibility DeterminationEpidermal Growth Factor ReceptorFDA approvedFoundationsFutureKRAS2 geneMalignant NeoplasmsManaged CareMedicineMethodsMonitorMutateMutationMutation AnalysisMutation DetectionPatientsPerformancePharmaceutical PreparationsPhasePlasmaRecoveryReproducibilitySamplingSerumSmall Business Innovation Research GrantSpecificitySpecimenSystemSystems AnalysisTechnologyTestingTissue SampleTissuesTumor TissueValidationWorkcancer careclinical applicationcommercializationcompanion diagnosticscostdetection testdigitalimprovedinnovationliquid biopsynovelsuccesstargeted treatmenttechnology platformtumorvalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The objective of this project is to further develop a breakthrough Toehold-Enrichment-
Extraction (TEE) technology and validate TEE-based tests for use in cancer detection and care
management. TEE is a novel DNA extraction method. Unlike conventional extraction methods,
TEE extracts mutated DNA while enriching it with high recovery. Moreover, unlike current PCR-
based enrichment methods, TEE enriches mutated DNA without altering original DNA sequences.
We have shown that TEE could enrich mutated DNA by as much as 1000 fold. Therefore, when
TEE is used to extract DNA for a mutation detection test, it significantly increases analytical
sensitivity of the test, leading to accurate detection of mutated DNA at a much lower concentration
level, which could not be achieved if a conventional method is used to extract DNA. To illustrate,
when a conventional method is used to extract DNA, Sanger sequencing cannot detect mutated
DNA if its concentration is less than 20%. In contrast, when TEE is used to extract mutated DNA,
it enables Sanger sequencing to detect 0.1% mutated DNA. In other words, Sanger-sequencing
becomes as sensitive as digital PCR or NGS when we incorporate TEE into Sanger sequencing
(we term this combination TEE-Sanger sequencing) for mutation analysis. Furthermore, we have
demonstrated that TEE-Sanger sequencing could detect mutated DNA from clinical specimen like
FFPE tumor tissue and blood (serum) samples, indicating that TEE-based testing is compatible
with clinical applications.
Since TEE is a DNA extraction method, it can replace conventional methods to extract
DNA for mutation analysis. Moreover, TEE is not only a breakthrough technology, but also a
platform on which various TEE-based tests can be developed for different clinical applications.
Inspired by the success of our preliminary study and potential of the TEE technology, we propose
this SBIR Phase II project to further study the TEE technology, providing a strong foundation for
its commercialization. This project has four specific aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Method for Efficiently and Robustly Retrieving Circulating miRNAs
-
批准号:10013246
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2019
-
负责人:Qipan Deng
-
依托单位:
海外基金